These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18981317)

  • 1. Aliskiren accumulates in Renin secretory granules and binds plasma prorenin.
    Krop M; Garrelds IM; de Bruin RJ; van Gool JM; Fisher ND; Hollenberg NK; Jan Danser AH
    Hypertension; 2008 Dec; 52(6):1076-83. PubMed ID: 18981317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aliskiren accumulation in the kidney: no major role for binding to renin or prorenin.
    Lange S; Fraune C; Alenina N; Bader M; Danser AH; Frenay AR; van Goor H; Stahl R; Nguyen G; Schwedhelm E; Wenzel UO
    J Hypertens; 2013 Apr; 31(4):713-9. PubMed ID: 23407438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells.
    Batenburg WW; de Bruin RJ; van Gool JM; Müller DN; Bader M; Nguyen G; Danser AH
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1151-7. PubMed ID: 18388329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New renin inhibitor VTP-27999 alters renin immunoreactivity and does not unfold prorenin.
    Krop M; Lu X; Verdonk K; Schalekamp MA; van Gool JM; McKeever BM; Gregg R; Danser AH
    Hypertension; 2013 May; 61(5):1075-82. PubMed ID: 23460288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin inhibitor VTP-27999 differs from aliskiren: focus on their intracellular accumulation and the (pro)renin receptor.
    Lu X; Krop M; Batenburg WW; Musterd-Bhaggoe UM; Garrelds IM; Danser AH
    J Hypertens; 2014 Jun; 32(6):1255-63. PubMed ID: 24637873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats.
    Feldman DL; Jin L; Xuan H; Contrepas A; Zhou Y; Webb RL; Mueller DN; Feldt S; Cumin F; Maniara W; Persohn E; Schuetz H; Jan Danser AH; Nguyen G
    Hypertension; 2008 Jul; 52(1):130-6. PubMed ID: 18490518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aliskiren: an oral direct renin inhibitor for the treatment of hypertension.
    Sanoski CA
    Pharmacotherapy; 2009 Feb; 29(2):193-212. PubMed ID: 19170589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Renin levels are not influenced by the amount of resident mast cells.
    Krop M; van Veghel R; Garrelds IM; de Bruin RJ; van Gool JM; van den Meiracker AH; Thio M; van Daele PL; Danser AH
    Hypertension; 2009 Aug; 54(2):315-21. PubMed ID: 19564544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.
    Gradman AH; Traub D
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S22-30. PubMed ID: 17401313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aliskiren therapy will have minimal effect on intracellular renin of renin-producing cells.
    Campbell DJ
    Hypertension; 2009 Feb; 53(2):e17; author reply e18. PubMed ID: 19124676
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects.
    Vaidyanathan S; Maboudian M; Warren V; Yeh CM; Dieterich HA; Howard D; Dole WP
    Curr Med Res Opin; 2008 Aug; 24(8):2313-26. PubMed ID: 18786303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of aliskiren/hydrochlorothiazide single-pill combination tablets and free combination of aliskiren and hydrochlorothiazide.
    Yan JH; Jarugula V; Sabo R; Papst CC; Zhang J; Dole WP
    J Clin Pharmacol; 2012 May; 52(5):645-55. PubMed ID: 21659626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide.
    Feldt S; Batenburg WW; Mazak I; Maschke U; Wellner M; Kvakan H; Dechend R; Fiebeler A; Burckle C; Contrepas A; Jan Danser AH; Bader M; Nguyen G; Luft FC; Muller DN
    Hypertension; 2008 Mar; 51(3):682-8. PubMed ID: 18212269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
    Vaidyanathan S; Valencia J; Kemp C; Zhao C; Yeh CM; Bizot MN; Denouel J; Dieterich HA; Dole WP
    Int J Clin Pract; 2006 Nov; 60(11):1343-56. PubMed ID: 17073832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational changes in prorenin during renin inhibition in vitro and in vivo.
    Ménard J; Guyene TT; Peyrard S; Azizi M
    J Hypertens; 2006 Mar; 24(3):529-34. PubMed ID: 16467656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine ovarian cells have (pro)renin receptors and prorenin induces resumption of meiosis in vitro.
    Dau AM; da Silva EP; da Rosa PR; Bastiani FT; Gutierrez K; Ilha GF; Comim FV; Gonçalves PB
    Peptides; 2016 Jul; 81():1-8. PubMed ID: 27060674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aliskiren binds to renin and prorenin bound to (pro)renin receptor in vitro.
    Biswas KB; Nabi AH; Arai Y; Nakagawa T; Ebihara A; Ichihara A; Watanabe T; Inagami T; Suzuki F
    Hypertens Res; 2010 Oct; 33(10):1053-9. PubMed ID: 20664543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin inhibition with aliskiren.
    Wuerzner G; Azizi M
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):426-30. PubMed ID: 18307734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of dose-proportionality in the pharmacokinetics of the oral direct renin inhibitor aliskiren in healthy subjects.
    Limoges D; Dieterich HA; Yeh CM; Vaidyanathan S; Howard D; Dole WP
    Int J Clin Pharmacol Ther; 2008 May; 46(5):252-8. PubMed ID: 18538111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.